Why WELL Health (TSX:WELL) Stock Is Surging 17% This Week

WELL Health Technologies (TSX:WELL) stock is quickly regaining lost ground as its acquisition spree continues.

| More on:

Telehealth star WELL Health Technologies (TSX:WELL) stock is quickly regaining lost ground. Over the past six days, the stock has surged 17%. It’s now within striking distance of its all-time high of $9.84. Here’s why this stock is gaining attention again and how far this rally could stretch in the year ahead. 

WELL Health stock rebound

WELL Health stock has been tightly correlated with the tech sector and stay-at-home stocks over the past year. Over the course of 2020, the company gained 500% in market value primarily driven by the adoption of the company’s virtual healthcare and medical data services. 

However, with the pandemic receding and growth stocks collapsing, WELL Health stock took a dip too. It’s been down roughly 25% from its all-time high in February. However, there are a number of reasons why WELL Health doesn’t deserve this correlation. 

For one, healthcare technology is insulated from the economy. WELL Health’s traction and adoption are not impacted by economic growth or interest rates. Second, the stock isn’t overvalued like the rest of the tech sector. While high-flying e-commerce and electric vehicle stocks trade at double-digit multiples of annual sales, WELL Health stock is trading at a forward price-to-sales ratio of around four. 

Finally, the company’s growth is driven by acquisitions and expansion in the United States. Yesterday, WELL Health’s CEO Hamid Shahbazi announced that the team has sealed a deal to acquire MyHealth for $206 million. This deal makes WELL Health “…the largest owner-operator of outpatient medical clinics and the leading multi-disciplinary telehealth service provider in Canada,” according to Shahbazi’s tweet. 

News about this acquisition was the perfect catalyst for the stock. It’s up 15% since yesterday. WELL Health seems to have plenty of room to grow further. 

Room to grow

Currently worth about $1.6 billion, WELL Health is still a tiny challenger in a massive market. The healthcare technology sector in North America is worth hundreds of billions. Across the world, this market could be worth trillions. 

The adoption of virtual healthcare and telehealth services was spurred by the pandemic, but it’s here to here to stay now. The convenience of receiving medical attention via video calls is undeniable. Meanwhile, WELL Health is backed by heavyweight investors like Hong Kong billionaire Sir Li Ka-shing. This means it has plenty of dry powder to keep acquiring small firms like MyHealth to sustain this pace of growth. 

Before its latest acquisition, WELL health was on track to generate $300 million in annual recurring revenue. Now, the acquisition probably pushes that number higher. Assuming the stock deserves a price-to-sales ratio of eight to 10, WELL Health stock could easily double in market value by the end of the year. 

Bottom line

WELL Health stock is surging again as news of its latest acquisition is made public. The purchase of MyHealth makes the company the largest private healthcare provider in Canada. This model is also being expanded in the U.S., which means investors have plenty of growth to look forward to. 

If the team can achieve its revenue growth targets and the market can offer a more reasonable valuation ratio, the stock could double before the end of the year. 

Fool contributor Vishesh Raisinghani owns shares of WELL Health Technologies. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

A child pretends to blast off into space.
Tech Stocks

2 Canadian Stocks That Could Surge Before 2026 Ends

Two smaller Canadian growth stocks could get a boost from upcoming results and big deals tied to data-centre power and…

Read more »

moving into apartment
Tech Stocks

Canada’s Smart Money Is Piling Into This TSX Leader

Major institutional investors are loading up on this Canadian tech stock after blowout growth. Here is why the smart money…

Read more »

man in bowtie poses with abacus
Dividend Stocks

What the Average Canadian TFSA Looks Like at Age 50

See what the average Canadian TFSA looks like at age 50 and how CNR, Constellation Software, and VFV could support…

Read more »

Senior uses a laptop computer
Dividend Stocks

A Canadian Dividend Stock Down 35% to Buy and Hold for Retirement

Rogers’ 13% dip has pushed its yield above 4%, and management expects a big jump in free cash flow.

Read more »

A patient takes medicine out of a daily pill box.
Tech Stocks

1 Undervalued Canadian Stock to Buy and Hold Forever

This small-cap healthcare software stock keeps winning long-term contracts and just got a governance stamp of approval.

Read more »

crisis concept, falling stairs
Tech Stocks

1 Canadian Stock Down 45% I’d Buy and Hold Now

Constellation Software’s 45% plunge looks scary, but its revenue and cash flow are still growing fast.

Read more »

The TFSA is a powerful savings vehicle for Canadians who are saving for retirement.
Dividend Stocks

3 Canadian Stocks Well-Suited for a Long-Term Buy-and-Hold TFSA

A simple TFSA mix of Shopify, CN Rail, and Royal Bank aims to compound for decades while keeping every gain…

Read more »

Women's fashion boutique Aritzia is a top stock to buy in September 2022.
Tech Stocks

What Are the Best High-Growth Canadian Stocks to Buy Now?

Three Canadian growth stocks look compelling, but they’re priced for success, so gradual buying and position sizing matter.

Read more »